Skip to content

News

Optellum Wins the Clinical Excellence & Evidence Award at MedTech World Asia Awards 2026

Optellum wins the Clinical Excellence & Evidence Award at MedTech World Asia 2026, highlighting our commitment to innovation in lung cancer diagnosis and treatment.

Read more

Optellum Wins the Clinical Excellence & Evidence Award at MedTech World Asia Awards 2026

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

16 June 2022 / Clinical & Regulatory

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

Optellum’s UK regulatory certification bolstered by UKCA marking for its early lung cancer diagnosis AI technology

The practical considerations of applying AI in healthcare settings

15 June 2022 / Insights

The practical considerations of applying AI in healthcare settings

The practical considerations of applying AI in healthcare settings

Optellum is attending the 2022 ASCO Annual Meeting

06 June 2022 / Events

Optellum is attending the 2022 ASCO Annual Meeting

Optellum is attending the 2022 ASCO Annual Meeting

PRESS RELEASE: Researchers Use AI to Predict Cancer Risk of Lung Nodules

28 May 2022 / News & Press

PRESS RELEASE: Researchers Use AI to Predict Cancer Risk of Lung Nodules

PRESS RELEASE: Researchers Use AI to Predict Cancer Risk of Lung Nodules

Optellum team amongst innovators attending the American Association for Thoracic Surgery 102nd annual meeting

26 May 2022 / Events

Optellum team amongst innovators attending the American Association for Thoracic Surgery 102nd annual meeting

Optellum team amongst innovators attending the American Association for Thoracic Surgery 102nd annual meeting

Optellum science features in posters at the American Thoracic Society annual meeting

23 May 2022 / Events

Optellum science features in posters at the American Thoracic Society annual meeting

Optellum science features in posters at the American Thoracic Society annual meeting

Optellum presents new discoveries in AI and Machine Learning

05 May 2022 / Partnerships

Optellum presents new discoveries in AI and Machine Learning

Optellum presents new discoveries in AI and Machine Learning

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

31 March 2022 / Clinical & Regulatory

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

PRESS RELEASE: Optellum attains CE marking for its early lung cancer diagnosis AI technology

Oxford study on Optellum software published in European Radiology

21 March 2022 / Customer stories

Oxford study on Optellum software published in European Radiology

Oxford study on Optellum software published in European Radiology

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

22 February 2022 / Partnerships

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Vanderbilt Lung Institute implements the Optellum Virtual Lung Nodule Clinic

04 January 2022 / Partnerships

Vanderbilt Lung Institute implements the Optellum Virtual Lung Nodule Clinic

Vanderbilt Lung Institute implements the Optellum Virtual Lung Nodule Clinic

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

26 November 2021 / Partnerships

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

14 September 2021 / US

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA

Optellum and J&J announce collaboration on lung cancer treatment

18 August 2021 / Partnerships

Optellum and J&J announce collaboration on lung cancer treatment

Optellum and J&J announce collaboration on lung cancer treatment

Optellum and J&J to Use AI to Transform Lung Cancer Treatment

18 August 2021 / Partnerships

Optellum and J&J to Use AI to Transform Lung Cancer Treatment

Optellum and J&J to Use AI to Transform Lung Cancer Treatment

Optellum announces strategic collaboration with the Lung Cancer initiative at Johnson & Johnson

18 August 2021 / Partnerships

Optellum announces strategic collaboration with the Lung Cancer initiative at Johnson & Johnson

Optellum announces strategic collaboration with the Lung Cancer initiative at Johnson & Johnson

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

18 August 2021 / Partnerships

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

18 August 2021 / Partnerships

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

Lung health startup partners with Johnson & Johnson’s lung cancer initiative

Optellum Collaborates with the Lung Cancer Initiative at J&J

18 August 2021 / Partnerships

Optellum Collaborates with the Lung Cancer Initiative at J&J

Optellum Collaborates with the Lung Cancer Initiative at J&J

Digital Health Roundup (subscription required)

18 August 2021 / US

Digital Health Roundup (subscription required)

Digital Health Roundup (subscription required)

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

18 August 2021 / Partnerships

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

The end of a death sentence: Václav Potěšil wants to detect cancer using artificial intelligence

09 August 2021 / Digital

The end of a death sentence: Václav Potěšil wants to detect cancer using artificial intelligence

The end of a death sentence: Václav Potěšil wants to detect cancer using artificial intelligence

101 Best United Kingdom Medical Device Startups

05 August 2021 / Digital

101 Best United Kingdom Medical Device Startups

101 Best United Kingdom Medical Device Startups

UK government funds AI software for lung cancer

09 July 2021 / Insights

UK government funds AI software for lung cancer

UK government funds AI software for lung cancer

Optellum is trusted by industry & academic leaders

Certification

UKCA-CE-mark

cert-1

Redefining early intervention of lung disease starting with one of the deadliest, lung cancer

Contact us